HK Stock Market Move | Policy support for the development of brain-machine interfaces. HEARTCARE-B (06609) rose more than 12%. BRAINAURORA-B (06681) rose nearly 8%.

Concept stocks related to brain-machine interface were strong in the morning session. As of the time of publication, HEARTCARE-B (06609) rose by 12.22% to HK$54; BRAINAURORA-B (06681) rose by 7.78% to HK$6.79; and NANJING PANDA (00553) rose by 7.14% to HK$4.65. On the news front, on December 26th, the National Medical Products Administration released the "Priority Approval Catalogue for High-End Medical Devices (2025 Edition)." The catalogue includes 8 products such as implantable brain-machine interface medical devices, and provides details on product technical parameters or expected uses. The National Medical Products Administration also clarified related matters. Sinolink believes that recent policies have shown strong support for innovation in medical devices. The National Medical Products Administration held a brain-machine interface medical device work promotion meeting in Beijing, actively promoting the faster and better market application of these devices. The application scenarios for brain-machine interfaces are diverse, with a rich variety of products and research and development paths. There is huge potential for future growth, and with support from product registration and medical insurance project policies, commercialization and popularization are expected to accelerate.